As subtypes stratified by receptor status suggest that the heterogeneity of genetic associations might result from different etiologic pathways, we also determined whether the presence of ER+/−, PR+/−, and HER2+/− subtype tumors modifies the association with breast cancer risk. The gene discussed is ESR1; the disease is breast carcinoma.